Connect with us

Technology

QuickLogic Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

Published

on

SAN JOSE, Calif. , Feb. 25, 2025 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK) (“QuickLogic” or the “Company”), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, today announced its financial results for the fiscal fourth quarter and fiscal year that ended December 29, 2024.

Recent Highlights

Awarded $1.1 million eFPGA Hard IP contract with new defense industrial base customer last weekAnnounced $6.6 million fourth tranche of the Strategic Radiation Hardened FPGA Technology US Government contractOn track to complete the first eFPGA Hard IP core optimized for Intel 18A during Q1Announced the integration of the Synopsys Synplify® synthesis tool into Aurora 2.9 Pro FPGA User ToolsStrengthened sales team with the appointment of former FlexLogix VP Andy Jaros to VP of IP SalesSigned distribution agreement with Magenta to expand distribution network to Turkiye and UAEAnnounced strategic process for SensiML

“With the continued execution on the Strategic Radiation Hardened FPGA contract with the US government, an influx of opportunities after a key competitor exited the market and being the first, and at this time, only company to offer eFPGA Hard IP for Intel 18A, we believe we are well positioned to return to sound revenue growth in 2025,” said Brian Faith, CEO of QuickLogic. “We believe this growth, combined with our ability to leverage the eFPGA Hard IP we have established for six unique fabrication processes and the Hard IP Cores in our library that are being reused; we believe we are very well positioned to achieve non-GAAP profitability and positive cash flow for full-year 2025.”

Fiscal Fourth Quarter 2024 Financial Results

Total revenue for the fourth quarter of fiscal 2024 was $5.7 million, a decrease of 23.7% compared with the fourth quarter of 2023 and an increase of 33.5% compared with the third quarter of 2024.

New product revenue was approximately $4.7 million in the fourth quarter of 2024, a decrease of $2.2 million, or 31.8%, compared with the fourth quarter of 2023 and an increase of $1.1 million, or 31.7%, compared with the third quarter of 2024. The decreases in total revenue and new product revenue from the same period a year ago were mostly due to the timing of awards for certain large eFPGA IP contracts.

Mature product revenue was $1.0 million in the fourth quarter of 2024. This compares to $0.7 million in the fourth quarter of 2023 and $0.7 million in the third quarter of 2024.

Fourth quarter 2024 GAAP gross margin was 59.8% compared with 77.1% in the fourth quarter of 2023 and 55.8% in the third quarter of 2024.

Fourth quarter 2024 non-GAAP gross margin was 62.0% compared with 78.3% in the fourth quarter of 2023 and 60.0% in the third quarter of 2024.

Fourth quarter 2024 GAAP operating expenses were $3.6 million compared with $3.7 million in the fourth quarter of 2023 and $4.2 million in the third quarter of 2024.

Fourth quarter 2024 non-GAAP operating expenses were $2.9 million compared with $3.1 million in the fourth quarter of 2023 and $3.3 million in the third quarter of 2024.

Fourth quarter 2024 GAAP net loss was ($0.3 million), or ($0.02) per share, compared with net income of $2.0 million, or $0.15 per basic share or $0.14 per diluted share, in the fourth quarter of 2023, and a net loss of ($2.1 million), or ($0.14) per share, in the third quarter of 2024.

Fourth quarter 2024 non-GAAP net income was $0.6 million, or $0.04 per share, compared with net income of $2.6 million, or $0.19 per basic share or $0.18 per diluted share, in the fourth quarter of 2023 and a net loss of ($0.9 million), or ($0.06) per share, in the third quarter of 2024.

Conference Call

QuickLogic will hold a conference call at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time today, February 25, 2025, to discuss its current financial results. The conference call will be webcast on QuickLogic’s IR Site Events Page at https://ir.quicklogic.com/ir-calendar. To join the live conference, you may dial (877) 407-0792 and international participants should dial (201) 689-8263 by 2:20 p.m. Pacific Time. No Passcode is needed to join the conference call. A recording of the call will be available approximately one hour after completion. To access the recording, please call (844) 512-2921 and reference the passcode 13751688.

The call recording, which can be accessed by phone, will be archived through March 4, 2025, and the webcast will be available for 12 months on the Company’s website.

About QuickLogic

QuickLogic is a fabless semiconductor company that develops innovative embedded FPGA (eFPGA) IP, discrete FPGAs, and FPGA SoCs for a variety of industrial, aerospace and defense, edge and endpoint AI, consumer, and computing applications. Our wholly owned subsidiary, SensiML Corporation, completes the end-to-end solution portfolio with AI / ML software that accelerates AI at the edge/endpoint. For more information, visit www.quicklogic.com.

QuickLogic uses its website (www.quicklogic.com), the company blog (https://www.quicklogic.com/blog/), corporate Twitter account (@QuickLogic_Corp), Facebook page (https://www.facebook.com/QuickLogic), and LinkedIn page (https://www.linkedin.com/company/13512/) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and QuickLogic may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor the Company’s website and its social media accounts in addition to following the Company’s press releases, SEC filings, public conference calls, and webcasts.

Non-GAAP Financial Measures

QuickLogic reports financial information in accordance with United States Generally Accepted Accounting Principles, or U.S. GAAP, but believes that non-GAAP financial measures are helpful in evaluating its operating results and comparing its performance to comparable companies. Accordingly, the Company excludes certain charges related to stock-based compensation, in calculating non-GAAP (i) income (loss) from operations, (ii) net income (loss), (iii) net income (loss) per share, and (iv) gross margin percentage. The Company provides this non-GAAP information to enable investors to evaluate its operating results in a manner like how the Company analyzes its operating results and to provide consistency and comparability with similar companies in the Company’s industry.

Management uses the non-GAAP measures, which exclude gains, losses, and other charges that are considered by management to be outside of the Company’s core operating results, internally to evaluate its operating performance against results in prior periods and its operating plans and forecasts. In addition, the non-GAAP measures are used to plan for the Company’s future periods and serve as a basis for the allocation of the Company’s resources, management of operations and the measurement of profit-dependent cash, and equity compensation paid to employees and executive officers.

Investors should note, however, that the non-GAAP financial measures used by QuickLogic may not be the same non-GAAP financial measures and may not be calculated in the same manner as that of other companies. QuickLogic does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures alone or as a substitute for financial information prepared in accordance with U.S. GAAP. A reconciliation of U.S. GAAP financial measures to non-GAAP financial measures is included in the financial statements portion of this press release. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of non-GAAP financial measures with their most directly comparable U.S. GAAP financial measures.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding our future profitability and cash flows, expectations regarding our future business and statements regarding the timing, milestones, and payments related to our government contracts, and statements regarding our ability to successfully exit SensiML, and actual results may differ due to a variety of factors including: delays in the market acceptance of the Company’s new products; the ability to convert design opportunities into customer revenue; our ability to replace revenue from end-of-life products; the level and timing of customer design activity; the market acceptance of our customers’ products; the risk that new orders may not result in future revenue; our ability to introduce and produce new products based on advanced wafer technology on a timely basis; our ability to adequately market the low power, competitive pricing and short time-to-market of our new products; intense competition by competitors; our ability to hire and retain qualified personnel; changes in product demand or supply; general economic conditions; political events, international trade disputes, natural disasters and other business interruptions that could disrupt supply or delivery of, or demand for, the Company’s products; and changes in tax rates and exposure to additional tax liabilities. These and other potential factors and uncertainties that could cause actual results to differ materially from the results contemplated or implied are described in more detail in the Company’s public reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including the risks discussed in the “Risk Factors” section in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and in the Company’s prior press releases, which are available on the Company’s Investor Relations website at http://ir.quicklogic.com/, and on the SEC website at www.sec.gov/. In addition, please note that the date of this press release is February 25, 2025, and any forward-looking statements contained herein are based on management’s current expectations and assumptions that we believe to be reasonable as of this date. We are not obliged to update these statements due to latest information or future events.

QuickLogic and logo are registered trademarks of QuickLogic. All other trademarks are the property of their respective holders and should be treated as such.

CODE: QUIK-E 

 –Tables Follow –

 

QUICKLOGIC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited) 

Three Months Ended

Year Ended

December 29, 2024

December 31, 2023

September 29, 2024

December 29, 2024

December 31, 2023

Revenue

$

5,705

$

7,479

$

4,273

$

20,112

$

21,198

Cost of revenue

2,292

1,713

1,888

$

8,226

6,711

Gross profit

3,413

5,766

2,385

$

11,886

14,487

Operating expenses:

Research and development

1,604

1,381

1,954

$

6,544

6,448

Selling, general and administrative

2,035

2,269

2,292

$

8,773

7,969

Total operating expense

3,639

3,650

4,246

$

15,317

14,417

Operating income (loss)

(226)

2,116

(1,861)

$

(3,431)

70

Interest expense

(111)

(59)

(186)

$

(406)

(215)

Interest and other (expense) income, net

21

(17)

(34)

$

(1)

(116)

Income (loss) before income taxes

(316)

2,040

(2,081)

$

(3,838)

(261)

(Benefit from) provision for income taxes

(11)

(2)

13

$

3

2

Net income (loss)

$

(305)

$

2,042

$

(2,094)

$

(3,841)

$

(263)

Net income (loss) per share:

Basic

$

(0.02)

$

0.15

$

(0.14)

$

(0.26)

$

(0.02)

Diluted

$

(0.02)

$

0.14

$

(0.14)

$

(0.26)

$

(0.02)

Weighted average shares outstanding:

Basic

14,869

13,989

14,555

14,510

13,453

Diluted

14,869

14,349

14,555

14,510

13,453

Note: Net income (loss) equals to comprehensive income (loss) for all periods presented.

 

QUICKLOGIC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

December 29, 2024

December 31, 2023

ASSETS

Current assets:

Cash, cash equivalents and restricted cash

$

21,880

$

24,606

Accounts receivable, net of allowance for doubtful accounts of $30 and $34, as of December 29, 2024 and December 31, 2023, respectively

2,436

1,625

Contract assets

2,682

3,609

Note receivable, current

1,200

Inventories

940

2,029

Prepaid expenses and other current assets

1,666

1,561

Total current assets

29,604

34,630

Property and equipment, net

16,077

8,948

Capitalized internal-use software, net

2,451

2,069

Right of use assets, net

758

981

Intangible assets, net

430

537

Non-marketable equity investment

300

300

Goodwill

185

185

Inventories, non-current

718

Note receivable, non-current

1,292

Other assets

118

142

TOTAL ASSETS

$

51,933

$

47,792

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Revolving line of credit

$

18,000

$

20,000

Trade payables

3,120

4,657

Accrued liabilities

1,611

2,673

Deferred revenue

454

1,052

Notes payable, current

1,928

946

Lease liabilities, current

284

302

Total current liabilities

25,397

29,630

Long-term liabilities:

Lease liabilities, non-current

447

681

Notes payable, non-current

1,202

461

Other long-term liabilities

125

Total liabilities

27,046

30,897

Commitments and contingencies

Stockholders’ equity:

Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding

Common stock, $0.001 par value; 200,000 authorized; 15,336 and 14,118 shares issued and outstanding as of December 29, 2024 and December 31, 2023, respectively

15

14

Additional paid-in capital

334,268

322,436

Accumulated deficit

(309,396)

(305,555)

Total stockholders’ equity

24,887

16,895

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

51,933

$

47,792

 

QUICKLOGIC CORPORATION

SUPPLEMENTAL RECONCILIATIONS OF US GAAP AND NON-GAAP FINANCIAL MEASURES

(in thousands, except per share amounts and percentages)

(Unaudited)

Three Months Ended

Year Ended

December 29, 2024

December 31, 2023

September 29, 2024

December 29, 2024

December 31, 2023

US GAAP income (loss) from operations

$

(226)

$

2,116

$

(1,861)

$

(3,431)

$

70

Adjustment for stock-based compensation within:

Cost of revenue

122

89

180

627

328

Research and development

171

82

323

1,048

595

Selling, general and administrative

575

434

645

2,706

1,599

Non-GAAP income (loss) from operations

$

642

$

2,721

$

(713)

$

950

$

2,592

US GAAP net income (loss)

$

(305)

$

2,042

$

(2,094)

$

(3,841)

$

(263)

Adjustment for stock-based compensation within:

Cost of revenue

122

89

180

627

328

Research and development

171

82

323

1,048

595

Selling, general and administrative

575

434

645

2,706

1,599

Non-GAAP net income (loss)

$

563

$

2,647

$

(946)

$

540

$

2,259

US GAAP net income (loss) per share, basic

$

(0.02)

$

0.15

$

(0.14)

$

(0.26)

$

(0.02)

Adjustment for stock-based compensation

0.06

0.04

0.08

0.30

0.19

Non-GAAP net income (loss) per share, basic

$

0.04

$

0.19

$

(0.06)

$

0.04

$

0.17

US GAAP net income (loss) per share, diluted

$

(0.02)

$

0.14

$

(0.14)

$

(0.26)

$

(0.02)

Adjustment for stock-based compensation

0.06

0.04

0.08

0.30

0.19

Non-GAAP net income (loss) per share, diluted

$

0.04

$

0.18

$

(0.06)

$

0.04

$

0.17

US GAAP gross margin percentage

59.8

%

77.1

%

55.8

%

59.1

%

68.3

%

Adjustment for stock-based compensation included in cost of revenue

2.2

%

1.2

%

4.2

%

3.1

%

1.6

%

Non-GAAP gross margin percentage

62.0

%

78.3

%

60.0

%

62.2

%

69.9

%

 

QUICKLOGIC CORPORATION

SUPPLEMENTAL DATA

(Unaudited)

Percentage of Revenue

Change in Revenue

Q4 2024

Q4 2023

Q3 2024

Q4 2024 to Q4 2023

Q4 2024 to Q3 2024

COMPOSITION OF REVENUE

Revenue by product: (1)

New products

82

%

91

%

83

%

(32)

%

32

%

Mature products

18

%

9

%

17

%

61

%

42

%

Revenue by geography:

Asia Pacific

9

%

6

%

12

%

28

%

5

%

North America

86

%

92

%

86

%

(29)

%

33

%

Europe

5

%

2

%

2

%

90

%

208

%

_____________________

(1)

New products include all products manufactured on 180 nanometer or smaller semiconductor processes, eFPGA IP intellectual property, professional services, and QuickAI and SensiML AI software as a service (SaaS) revenue. Mature products include all products produced on semiconductor processes larger than 180 nanometer and includes related royalty revenue.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quicklogic-reports-fiscal-fourth-quarter-and-full-year-2024-financial-results-302385240.html

SOURCE QuickLogic Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple

Published

on

By

The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.

AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.

The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.

The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.

The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.

According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.

The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.

Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.

The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.

The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.

What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html

SOURCE HelloNation

Continue Reading

Technology

CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group

Published

on

By

Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.

ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.

Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.

“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”

Key Challenges IT Leaders Face in Regulatory Response

Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:

Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.

Info-Tech’s Framework for Building a Regulatory IT Response Engine

To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:

Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.

Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.

The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.

For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026

Published

on

By

LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.

The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.

https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw

About Atomera

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html

SOURCE Atomera Incorporated

Continue Reading

Trending